Patient and tumor characteristics
Characteristics | Median (range), n (%) |
All cases, n | 10 |
Age, year | 63.5 (46–74) |
BMI (kg/m2) | 30.0 (21.5–40.1) |
Platinum-free interval (months) | 24 (17–145) |
Pre-operative CA125 (U/mL) | 43 (7–1292) |
Cytoreduction status | |
Secondary | 8 (80%) |
Tertiary | 2 (20%) |
FIGO stage at diagnosis | |
IIC | 1 (10%) |
IIIB | 2 (20%) |
IIIC | 6 (60%) |
IV | 1 (10%) |
Histopathologic subtype | |
Serous | 8 (80%) |
Granulosa cell | 1 (10%) |
Malignant mixed Müllerian tumor (MMMT) | 1 (10%) |
Tumor grade | |
1 | 1/10 (10%) |
2 or 3 | 9/10 (90%) |
Status of primary debulking | |
R0 | 9 (90%) |
R1–2 | 1 (10%) |
Status post-splenectomy | |
R0 | 10 (100%) |
Recurrence post-splenectomy | |
Yes | 5/10 (50%) |
No | 5/10 (50%) |
BMI, body mass index; CA125, cancer antigen 125; FIGO, International Federation of Gynecology and Obstetrics; R0, resection for cure or complete remission; R1, resection to microscopic residual tumor; R2, resection to macroscopic residual tumor.